Skofljica, Slovenia

Janez Ilaš

This inventor holds 1 USPTO granted patent. Top assignees: Szegedi Biológiai Kutatóközpont, Univerza V Ljubljani. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Janez Ilaš: Innovator in Antibiotic Development

Introduction

Janez Ilaš is a notable inventor based in Škofljica, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target bacterial infections. His work is characterized by a focus on innovative solutions to combat antibiotic resistance.

Latest Patents

Janez Ilaš holds a patent for a class of DNA gyrase and/or topoisomerase IV inhibitors with activity against both gram-positive and gram-negative bacteria. The present invention relates to compounds having a structure of general formula (I), processes for their preparation, and pharmaceutical compositions containing them as the active ingredient. These compounds are intended for use as medicaments in the treatment of bacterial infections in humans and warm-blooded animals.

Career Highlights

Throughout his career, Ilaš has been associated with prominent institutions such as the University of Ljubljana and Szeged Biological Research Center. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Tihomir Tomašič and Nace Zidar. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Janez Ilaš exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to antibiotic development are crucial in addressing the challenges posed by bacterial infections. His work continues to inspire future research and development in this vital area of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…